Thomasclavelia ramosa is a Signature of Gut Dysbiosis associated with Alcohol-Related Hepatocellular Carcinoma: A First Microbial Culturomics Study

Reham Magdy Wasfy,Anissa ABDOULAYE,Patrick BORENTAIN,Babacar MBAYE,Maryam TIDJANI ALOU,Aurelia CAPUTO,Claudia ANDRIEU,Giovanna MOTTOLA,Anthony LEVASSEUR,Matthieu Million,Rene GEROLAMI
DOI: https://doi.org/10.1101/2024.08.19.24312231
2024-08-20
Abstract:Background: Gut microbiota alteration is implicated in the pathogenesis of alcoholic liver disease (ALD) and HCC. No study has characterized the dysbiosis associated with ALD by microbial culturomics, an approach that certifies viability and allows the characterization of pathobiont strain candidates. Methods: A case-control study was conducted on patients with ALD without HCC (ALD-NoHCC) (n=16), ALD with HCC (ALD-HCC) (n=19), and controls (n=24). 16S rRNA amplicon sequencing and microbial culturomics were used as complementary methods for gut microbiome profiling. Results: By microbial culturomics, Thomasclavelia ramosa was the most enriched and detected in all ALD samples (100%), while it was cultivated in only a small proportion of controls (20%, p < 0.001). By 16S rRNA amplicon sequencing and 3-groups linear discriminant analysis, T. ramosa was increased explicitly in the ALD-HCC group (LDA-score > 5, p < 0.05). Conclusions: T. ramosa, identified by culturomics and 16 rRNA sequencing, is associated with ALD and ALD-HCC. Alongside the recently reported in vitro genotoxicity of this species in colorectal cancer, this species has been identified as a candidate oncobiont in ALD-HCC.
What problem does this paper attempt to address?
The problem this paper attempts to address is the characterization of the gut microbiome in patients with alcoholic liver disease (ALD) and its associated hepatocellular carcinoma (HCC) through microbial culturomics and 16S rRNA sequencing technology. Specifically, the main finding of the study is the identification of a bacterium named Thomasclavelia ramosa, which is significantly associated with ALD and ALD-related HCC. This discovery is based on a rigorously screened case-control study and combines two complementary methods—microbial culturomics and genetic sequencing technology—thereby enhancing the reliability of the results. Additionally, the study found that several other bacteria, such as some species of the genus Enterocloster, are also enriched in ALD patients. These findings provide new insights into the pathogenesis of alcoholic liver disease and its associated cancer and may open new avenues for future diagnosis and treatment.